Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Hypocalcemia 1Hyperparathyroidism, Secondary 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Cyclophosphamide 3pembrolizumab 2Radiotherapy 2Radiation 2Gemcitabine 2Etoposide 2Doxorubicin 2Cryotherapy 2Cryosurgery 2tocilizumab 1selinexor 1robatumumab 1poly ICLC 1olaparib 1montanide ISA 51 1lentiviral minigene vaccine of COVID-19 coronavirus 1flt3 ligand protein 1eltrombopag 1cc-486 1Vincristine 1Trabectedin 1Temozolomide 1Radiotherapy, Intensity-Modulated 1Leukapheresis 1Irinotecan 1Interleukin-2 1Injections 1Imiquimod 1Ifosfamide 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Bone Neoplasms × Calcifediol × Clear all
NCT02274623 2019-09-27

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

OPKO Health, Inc.

Phase 1 Completed
33 enrolled
BreastGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Breast Neoplasms, Hyperparathyroidism, Secondary, Hypocalcemia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡